CD8A and neoplasm: Alternatively, patients with LM who are non-responders may have genetic polymorphisms that influence the secretion of interleukin-10, an inhibitory cytokine that slows the generation of CD4 and CD8 effector T cells, which are able to kill tumor cells [23,25].